Elevance Health Inc (ELV · NYSE)
ELV · MARKET VIEW
Market view · as of Oct 12, 2026
Price (last ~year)
Elevance Health shares rose 2.9% to $412.70, extending a 3-month gain of 11.1% and sitting 2.9% below their 52-week high, though the stock remains down 1.4% over the past month. The company has beaten earnings estimates in all four of its most recent quarters, including Q2 2026 EPS of $7.45 versus $6.18 expected, but earnings fell 13.1% year over year while revenue grew just 1.4% to a TTM of $201.11B. Quarterly results show sequential softening, with operating income declining from $2.66B in Q1 2026 to $2.06B in Q2, alongside a thin 2.5% profit margin and $31.04B in total debt. Cantor Fitzgerald maintained its Overweight rating and $450 price target despite Elevance's 2027 Medicare Stars rating declining from 54.00% to 47.00%.
Valuation
- Market cap
- $89.50B
- P/E
- 18.27
- PEG
- 1.304
- P/B
- 1.926
- P/S
- 0.445
- Beta
- 0.711
- Analyst target
- $451.48
Quality & returns
- Gross margin
- 26.0%
- Operating margin
- 4.6%
- Profit margin
- 2.5%
- ROE
- 11.1%
- ROA
- 3.8%
Price movement
- Last
- $412.70
- 1-month
- -1.4%
- 3-month
- +11.1%
- RSI (14)
- 53
- vs SMA200
- +13.2%
- 52-wk position
- 91.7% -2.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $50.47B | $2.06B | $1.46B | $2.36B |
| 2026-03-31 | $50.18B | $2.66B | $1.76B | $3.02B |
| 2025-12-31 | $49.75B | $581.0M | $547.0M | $987.0M |
| 2025-09-30 | $50.71B | $1.76B | $1.19B | $2.14B |
Recent news
- Neutral HCA Healthcare stock sits at EUR 402.10, market cap USD 97.5 billion · 2026-10-09
- Neutral Cigna Group stock at EUR 252.30 with USD 74.7 billion value · 2026-10-09
- Neutral Humana soars, Alignment plummets in 2027 Medicare Advantage star ratings · 2026-10-09
- Somewhat-Bullish Elevance Health Inc. stock outperforms competitors on strong trading day · 2026-10-09
- Somewhat-Bullish Cantor Fitzgerald keeps Overweight on Elevance Health stock · 2026-10-09
- Somewhat-Bullish Humana stock hits 52-week high at 450.23 USD · 2026-10-09
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)